In vitro targeting of Polo-like kinase 1 in bladder carcinoma-Reference-Cited by-同舟云学术

In vitro targeting of Polo-like kinase 1 in bladder carcinoma

Published:2013-07-10 Issue:7 Volume:14 Page:648-657
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Brassesco María Sol,Pezuk Julia Alejandra,Morales Andressa Gois,Carvalho de Oliveira Jaqueline,Roberto Gabriela Molinari,Nicioli da Silva Glenda,Francisco de Oliveira Harley,Scrideli Carlos Alberto,Tone Luiz Gonzaga

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.4161/cbt.25087

Reference43 articles.

1. Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control

2. M-Vac (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Advanced Transitional Cell Carcinoma of the Urothelium

3. Challenges in the treatment of bladder cancer

4. Overexpression of Polo-Like Kinase 1 (PLK1) and Chromosomal Instability in Bladder Cancer

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning-based autophagy-related prognostic signature for personalized risk stratification and therapeutic approaches in bladder cancer;International Immunopharmacology;2024-09

2. Cell cycle machinery in oncology: A comprehensive review of therapeutic targets;The FASEB Journal;2024-06-07

3. BI6727 and GSK461364A, potent PLK1 inhibitors induce G2/M arrest and apoptosis against cholangiocarcinoma cell lines;Pathology - Research and Practice;2023-08

4. A novel cuproptosis-related lncRNAs signature predicts prognostic and immune of bladder urothelial carcinoma;Frontiers in Genetics;2023-03-31

5. Present and Future Perspective on PLK1 Inhibition in Cancer Treatment;Frontiers in Oncology;2022-06-02